Loading...
Loading...
Market Overview: EMR closed at 148.13 on February 13, 2026, reflecting a modest gain of 0.25% from the previous close despite a 30-day decline of 6.23%. The stock remains in an uptrend supported by recent price action. Analyst price targets generally range near current levels, with some forecasts between 155 and 160. No imminent events are noted within the next 30 days. Technically, EMR trades above its 20-day SMA of 147.54, with the 50-day and 200-day SMAs not specified. The RSI is neutral, and key support and resistance levels are near 144.10 and 159.09, respectively. For information only. Last Updated 2/13/26

Sam Bourgi is an analyst, writer and financial market commentator featured in and cited by U.S. Congress, Department of Justice, Chicago Board Options Exchange, Barron's and Forbes. He covers stocks, bonds, mutual funds, ETFs, forex, Bitcoin, cryptocurrency, real estate and macroeconomics. He has written over 25,000 articles and over 40 whitepapers and e-books.